Carla Oliveira’s Lab

93 posts

Carla Oliveira’s Lab

Carla Oliveira’s Lab

@COliveiraLabi3S

Mentally in gastric cancer, genetics, iPSCs, bioinformatics, chromatin architecture, organoids Physically @i3S_UPorto

Porto, Portugal Katılım Eylül 2022
118 Takip Edilen213 Takipçiler
Sabitlenmiş Tweet
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
We are thrilled to share our latest results on the impact of #CTNNA1 germline variants in #HDGC, just published in #GUT! We report a significant risk of developing diffuse gastric in carriers of loss-of-function CTNNA1 germline variants carriers. ➡️🔗gut.bmj.com/content/early/…
English
0
6
11
4.4K
Carla Oliveira’s Lab retweetledi
Preventable
Preventable@Preventable_EU·
🔬✨ Carla Oliveira, the coordinator of Preventable, a researcher and the leader of the i3S group Regulation of Expression in Cancer, opens a window into her daily life in science and the impact of her research on society.
English
0
1
1
56
Carla Oliveira’s Lab retweetledi
Rare Disease Day
Rare Disease Day@rarediseaseday·
💜🌍 Today is Rare Disease Day! 🌍💜 Together, we stand with the 300 million people worldwide living with rare diseases. In uniting on this day we can raise awareness, advocate for change, and promote a more equitable future! ⚖️ Learn more: rarediseaseday.org
Rare Disease Day tweet media
English
5
414
629
94.7K
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
ERiC group is at the #ASHG2024 Stay tuned for the pioneer works of @SilvanaLobo21 on CTNNA1-related predisposition on Friday at 1:30pm of session 84 and @SaoJoseCelina poster on regulatory elements and 3D chromatin solving the missing heritability in HDGC on Friday at 2:30pm
Carla Oliveira’s Lab tweet media
English
0
1
12
733
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Happy to show our latest data on costs of prevention vs treatment of advanced HDGC-associated tumours. Preventive measures cost 6-fold less than treatment of advanced disease in patients with median overall survival of 2,5 months @Preventable_EU
Carla Oliveira’s Lab tweet mediaCarla Oliveira’s Lab tweet media
English
0
3
19
376
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Delighted to be invited to speak at the CGA-IGC and present the latest updates of the IGCLC 2024 consensus meeting, which will generate the updated HDGC clinical guidelines. Stay tuned for this great meeting 📣📣
CGA-IGC@CGAIGC

Our invited speaker at #CGAIGC24, Carla Oliveira is the Group Leader/Principal Investigator of the Expression Regulation in Cancer Group at i3S Porto (@COliveiraLabi3S) & an Affiliated Professor at the @UPorto Faculty of Medicine. Read more about her work: bit.ly/401PYUM

English
0
0
10
264
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Proud of @DAG_Ferreira for being awarded a #CaixaImpulse Innovation project to identify biomarkers for early diagnosis in #HDGC using a stomach-on-chip model. This project has the potential to improve the pathways of care of gastric and breast cancer at-risk individuals
Daniel Ferreira@DAG_Ferreira

It is a pleasure to become part of the CaixaResearch Team. A special thank word to the Expression in Regulation in Cancer Team for making this project a reality.

English
2
0
15
227
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Don’t miss this journalistic piece on one Portuguese family carrying a founder #CDH1 variant with hereditary diffuse gastric cancer. A perfect example of when science helps save lives #HDGC
i3S-Instituto de Investigação e Inovação em Saúde@i3S_UPorto

Don't miss this work from Público on the Hereditary diffuse gastric cancer syndrome, its impact on the lives of patients and the power of science. publico.pt/2024/06/19/cie… (in English) tinyurl.com/34zfuwvk (em PT) #i3Snews #i3Sresearch #cancer

English
0
6
17
1K
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Huge pleasure to have the input of HDGC patients on the development of the latest HDGC guidelines. More than numbers and samples, it is important to remember for whom we work everyday, for life-saving measures and overall better quality of life.
Carla Oliveira’s Lab tweet mediaCarla Oliveira’s Lab tweet media
English
0
4
25
694
Carla Oliveira’s Lab
Carla Oliveira’s Lab@COliveiraLabi3S·
Happy to have organised the latest IGCLC consensus meeting to define guidelines for genetic testing, management and treatment of HDGC patients. Glad to count with experts from 20 countries around 4 continents and 37 patients (6 countries), some with a founder CDH1 mutation in PT.
Carla Oliveira’s Lab tweet mediaCarla Oliveira’s Lab tweet mediaCarla Oliveira’s Lab tweet mediaCarla Oliveira’s Lab tweet media
English
2
3
21
2.2K